Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story
Nicola Baker, Harry P. de Koning, Pascal Mäser, et al.
Trends in Parasitology (2013) Vol. 29, Iss. 3, pp. 110-118
Open Access | Times Cited: 233

Showing 26-50 of 233 citing articles:

Antiparasitic Chemotherapy: From Genomes to Mechanisms
David Horn, Manoj T. Duraisingh
The Annual Review of Pharmacology and Toxicology (2013) Vol. 54, Iss. 1, pp. 71-94
Open Access | Times Cited: 58
Drug target identification in protozoan parasites
Joachim Müller, Andrew Hemphill
Expert Opinion on Drug Discovery (2016) Vol. 11, Iss. 8, pp. 815-824
Open Access | Times Cited: 58
Adult blood-feeding tsetse flies, trypanosomes, microbiota and the fluctuating environment in sub-Saharan Africa
Anne Geiger, Fleur Ponton, Gustave Simo
The ISME Journal (2014) Vol. 9, Iss. 7, pp. 1496-1507
Open Access | Times Cited: 56
Chimerization at the AQP2–AQP3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates
Fabrice E. Graf, Nicola Baker, Jane C. Munday, et al.
International Journal for Parasitology Drugs and Drug Resistance (2015) Vol. 5, Iss. 2, pp. 65-68
Open Access | Times Cited: 52
Justicidin B: A Promising Bioactive Lignan
Shiva Hemmati, Hassan Seradj
Molecules (2016) Vol. 21, Iss. 7, pp. 820-820
Open Access | Times Cited: 52
Drug Resistance in Protozoan Parasites: An Incessant Wrestle for Survival
Pijush Kanti Pramanik, Md Nur Alam, Dibyapriya Roy Chowdhury, et al.
Journal of Global Antimicrobial Resistance (2019) Vol. 18, pp. 1-11
Closed Access | Times Cited: 44
An Investigation into the Protein Composition of the Teneral Glossina morsitans morsitans Peritrophic Matrix
Clair Rose, Rodrigo Belmonte, Stuart D. Armstrong, et al.
PLoS neglected tropical diseases (2014) Vol. 8, Iss. 4, pp. e2691-e2691
Open Access | Times Cited: 51
Functional analysis of drug resistance‐associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein
Jane C. Munday, Daniel N. A. Tagoe, Anthonius A. Eze, et al.
Molecular Microbiology (2015) Vol. 96, Iss. 4, pp. 887-900
Open Access | Times Cited: 47
Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity
Fabian Hulpia, Gustavo D. Campagnaro, Mirko Scortichini, et al.
European Journal of Medicinal Chemistry (2018) Vol. 164, pp. 689-705
Open Access | Times Cited: 45
African Trypanosomes Undermine Humoral Responses and Vaccine Development: Link with Inflammatory Responses?
Benoı̂t Stijlemans, Magdalena Radwanska, Carl De Trez, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 44
The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!
Daniel N. A. Tagoe, Titilola D. Kalejaiye, Harry P. de Koning
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 43
Aquaglyceroporin-null trypanosomes display glycerol transport defects and respiratory-inhibitor sensitivity
Laura Jeacock, Nicola Baker, Natalie Wiedemar, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 3, pp. e1006307-e1006307
Open Access | Times Cited: 41
Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles
Ning Zhang, Martin Zoltner, Ka-Fai Leung, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 2, pp. e1006850-e1006850
Open Access | Times Cited: 41
The trypanosome alternative oxidase: a potential drug target?
Stefanie K. Menzies, L.B. Tulloch, Gordon J. Florence, et al.
Parasitology (2016) Vol. 145, Iss. 2, pp. 175-183
Open Access | Times Cited: 40
Stiff‐Stilbene Ligands Target G‐Quadruplex DNA and Exhibit Selective Anticancer and Antiparasitic Activity
Michael O’Hagan, Pablo Peñalver, Rosina S. L. Gibson, et al.
Chemistry - A European Journal (2020) Vol. 26, Iss. 28, pp. 6224-6233
Open Access | Times Cited: 34
Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments
Daniel Juárez-López, Alejandro Schcolnik‐Cabrera
Archives of Medical Research (2020) Vol. 52, Iss. 3, pp. 243-251
Closed Access | Times Cited: 34
Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei
Ali Al-Ghamdi, Jane C. Munday, Gustavo D. Campagnaro, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 33
QSAR Modeling for Multi-Target Drug Discovery: Designing Simultaneous Inhibitors of Proteins in Diverse Pathogenic Parasites
Valeria V. Kleandrova, Luciana Scotti, Francisco Jaime Bezerra Mendonça, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 28
Cloning and Characterization of Trypanosoma congolense and T. vivax Nucleoside Transporters Reveal the Potential of P1-Type Carriers for the Discovery of Broad-Spectrum Nucleoside-Based Therapeutics against Animal African Trypanosomiasis
Marzuq A. Ungogo, Mustafa M. Aldfer, Manal J. Natto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3144-3144
Open Access | Times Cited: 12
Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei
Karol R. Francisco, Ludovica Monti, Wenqian Yang, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 81, pp. 129123-129123
Open Access | Times Cited: 11
Population genetics of Glossina palpalis gambiensis in the sleeping sickness focus of Boffa (Guinea) before and after eight years of vector control: no effect of control despite a significant decrease of human exposure to the disease
Moïse Kagbadouno, Modou Séré, Adeline Ségard, et al.
Peer Community Journal (2024) Vol. 4
Open Access | Times Cited: 4
Identification of constrained peptidomimetics carrying a Michael acceptor warhead as antitrypanosomal agents
Santo Previti, Elsa Calcaterra, Carla Di Chio, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117389-117389
Open Access
Controlling Rate of Release of Tsetse Fly Repellent Blend by Encapsulating in β‐Cyclodextrin Nanoparticles
Bernadatte Moraa Ratemo, Benson M. Wachira, Eric Masika, et al.
Journal of Nanotechnology (2025) Vol. 2025, Iss. 1
Open Access
Antiprotozoal activity of Khaya anthotheca, (Welv.) C.D.C. a plant used by chimpanzees for self-medication
C.J.D. Obbo, Boris Makanga, Dulcie A. Mulholland, et al.
Journal of Ethnopharmacology (2013) Vol. 147, Iss. 1, pp. 220-223
Open Access | Times Cited: 38
Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads
Surendra Jain, Melissa R. Jacob, Larry Walker, et al.
BMC Complementary and Alternative Medicine (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 38

Scroll to top